| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Cattedra di Endocrinologia (A.B., E.C., S.F.), Dipartimento di Medicina Sperimentale e Clinica, Facolta di Medicina e Chirurgia; and Cattedra di Farmacologia (D.R.), Facolta di Farmacia, Universita degli Studi di Catanzaro, 88100 Catanzaro, Italy
Address all correspondence and requests for reprints to: Sebastiano Filetti, M.D., Cattedra di Endocrinologie, Dipartimento di Medicina Sperimentale e Clinica, via T. Campanella, 88100 Catanzaro, Italy. E-mail: filetti{at}tin.it
In human normal thyrocytes, the cAMP-responsive signaling pathway plays
a central role in gene regulation, cell proliferation, and
differentiation. Constitutive activation of the cAMP signal
transduction system has been documented in thyroid autonomously
hyperfunctioning adenomas in which activating mutations in either the
TSH receptor gene or the Gs
protein gene (gsp oncogene) have been
described. The molecular mechanism whereby cAMP induces thyrocyte
proliferation is unknown, but recent evidence suggests that the
transcription factor cAMP response element binding protein (CREB) may
serve as an important biochemical intermediate in this proliferative
response. Herein we have investigated the expression of CREB in normal
and tumoral thyroid tissues from a series of ten unrelated patients
with autonomously hyperfunctioning adenomas, previously screened for
mutations in the TSH receptor and Gs
genes. In all tumors examined,
the expression of the activated, phosphorylated form of CREB was
markedly reduced compared with that of the corresponding paired normal
thyroid tissue, and this reduction was independent of the presence of
mutations in the TSH receptor gene and Gs
gene. Moreover, no
correlation was observed in these tissues between CREB phosphorylation
and either protein kinase A activity or protein phosphatase expression.
Thus, these data suggest that in human hyperfunctioning thyroid
adenomas, the PKA/CREB system does not play a role in cell
proliferation.
This article has been cited by other articles:
![]() |
C. Brewer, N. Yeager, and A. Di Cristofano Thyroid-Stimulating Hormone Initiated Proliferative Signals Converge In vivo on the mTOR Kinase without Activating AKT Cancer Res., September 1, 2007; 67(17): 8002 - 8006. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, G. Baker, D. Janus, C. A. Paddon, D. Fuhrer, and M. Ludgate Biological Effects of Thyrotropin Receptor Activation on Human Orbital Preadipocytes Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5197 - 5203. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fuhrer, M. D. Lewis, F. Alkhafaji, K. Starkey, R. Paschke, D. Wynford-Thomas, M. Eggo, and M. Ludgate Biological Activity of Activating Thyroid-Stimulating Hormone Receptor Mutants Depends on the Cellular Context Endocrinology, September 1, 2003; 144(9): 4018 - 4030. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gereben, D. Salvatore, J. W. Harney, H. M. Tu, and P. R. Larsen The Human, but Not Rat, dio2 Gene Is Stimulated by Thyroid Transcription Factor-1 (TTF-1) Mol. Endocrinol., January 1, 2001; 15(1): 112 - 124. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |